These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 24116999)

  • 1. CD3ζ-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy.
    Bridgeman JS; Ladell K; Sheard VE; Miners K; Hawkins RE; Price DA; Gilham DE
    Clin Exp Immunol; 2014 Feb; 175(2):258-67. PubMed ID: 24116999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise and potential pitfalls of chimeric antigen receptors.
    Sadelain M; Brentjens R; Rivière I
    Curr Opin Immunol; 2009 Apr; 21(2):215-23. PubMed ID: 19327974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At The Bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies.
    Oluwole OO; Davila ML
    J Leukoc Biol; 2016 Dec; 100(6):1265-1272. PubMed ID: 27354412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies.
    Daniyan AF; Brentjens RJ
    J Leukoc Biol; 2016 Dec; 100(6):1255-1264. PubMed ID: 27789538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells.
    Frigault MJ; Lee J; Basil MC; Carpenito C; Motohashi S; Scholler J; Kawalekar OU; Guedan S; McGettigan SE; Posey AD; Ang S; Cooper LJ; Platt JM; Johnson FB; Paulos CM; Zhao Y; Kalos M; Milone MC; June CH
    Cancer Immunol Res; 2015 Apr; 3(4):356-67. PubMed ID: 25600436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions.
    Curran KJ; Pegram HJ; Brentjens RJ
    J Gene Med; 2012 Jun; 14(6):405-15. PubMed ID: 22262649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of the T cell receptor-associated CD3gamma-ITAM to thymocyte selection.
    Haks MC; Pépin E; van den Brakel JH; Smeele SA; Belkowski SM; Kessels HW; Krimpenfort P; Kruisbeek AM
    J Exp Med; 2002 Jul; 196(1):1-13. PubMed ID: 12093866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safer CARS.
    Heslop HE
    Mol Ther; 2010 Apr; 18(4):661-2. PubMed ID: 20357776
    [No Abstract]   [Full Text] [Related]  

  • 9. ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.
    Guedan S; Chen X; Madar A; Carpenito C; McGettigan SE; Frigault MJ; Lee J; Posey AD; Scholler J; Scholler N; Bonneau R; June CH
    Blood; 2014 Aug; 124(7):1070-80. PubMed ID: 24986688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Cytoplasmic Signaling of CD28ζ CARs for Improved Therapeutic Functions.
    Meng X; Jing R; Qian L; Zhou C; Sun J
    Front Immunol; 2020; 11():1046. PubMed ID: 32636832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack.
    Chmielewski M; Hombach AA; Abken H
    Gene Ther; 2011 Jan; 18(1):62-72. PubMed ID: 20944680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor.
    Fisher J; Abramowski P; Wisidagamage Don ND; Flutter B; Capsomidis A; Cheung GW; Gustafsson K; Anderson J
    Mol Ther; 2017 May; 25(5):1234-1247. PubMed ID: 28341563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and molecular characterization of human chimeric T-cell antigen receptors specific for carcinoembryonic antigen.
    Shirasu N; Shibaguci H; Kuroki M; Yamada H; Kuroki M
    Anticancer Res; 2010 Jul; 30(7):2731-8. PubMed ID: 20683006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive T-cell therapy of B-cell malignancies: conventional and physiological chimeric antigen receptors.
    Liu L; Sun M; Wang Z
    Cancer Lett; 2012 Mar; 316(1):1-5. PubMed ID: 22099879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it safer CARs that we need, or safer rules of the road?
    Junghans RP
    Mol Ther; 2010 Oct; 18(10):1742-3. PubMed ID: 20885432
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia.
    Tasian SK; Kenderian SS; Shen F; Ruella M; Shestova O; Kozlowski M; Li Y; Schrank-Hacker A; Morrissette JJD; Carroll M; June CH; Grupp SA; Gill S
    Blood; 2017 Apr; 129(17):2395-2407. PubMed ID: 28246194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating cancer with genetically engineered T cells.
    Park TS; Rosenberg SA; Morgan RA
    Trends Biotechnol; 2011 Nov; 29(11):550-7. PubMed ID: 21663987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of late activation events by Igbeta signaling subunit of B-cell receptor in Jurkat T-cell without tyrosine phosphorylation.
    Lim JH; Kim SW; Song YS; Lee SK
    Mol Cells; 1998 Aug; 8(4):408-15. PubMed ID: 9749527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of malignant solid tumors by targeting erbB2 receptors and by activating T cells.
    Hu WX; Chen HP; Yu K; Shen LX; Wang CY; Su SZ; Sui WJ; Shan DM; Li HZ
    Cancer Biother Radiopharm; 2012 Dec; 27(10):711-8. PubMed ID: 22988969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.
    Fisher J; Sharma R; Don DW; Barisa M; Hurtado MO; Abramowski P; Porter L; Day W; Borea R; Inglott S; Anderson J; Pe'er D
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.